Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
C. R. LoParco, R. A. Yockey, V. K. Sekhon, S. Olsson, R. Galindo, R. Balasundaram, T. Agwuncha & M. E. Rossheim. (2024) Kratom Retail Availability in Fort Worth, Texas. Journal of Psychoactive Drugs 56:1, pages 8-13.
Read now
Read now
Matthew S. Ellis, Mance E. Buttram, Alyssa Forber & Joshua C. Black. (2023) Associations Between Kratom-Related State Policy Environments and Kratom Use in a Nationally Representative Population in the United States. Journal of Psychoactive Drugs 0:0, pages 1-9.
Read now
Read now
Ibrahim M. Sablaban & Mohan Gautam. (2023) Kratom & Stimulant Co-Addiction: A Case Series and Brief Review. Journal of Addictive Diseases 41:2, pages 181-184.
Read now
Read now
Kirsten E. Smith, Jeffrey M. Rogers & Justin C. Strickland. (2022) Associations of Lifetime Nonmedical Opioid, Methamphetamine, and Kratom Use within a Nationally Representative US Sample. Journal of Psychoactive Drugs 54:5, pages 429-439.
Read now
Read now
Megan Webb & O. Hayden Griffin$suffix/text()$suffix/text(). (2020) A Mild Panic? Media Accounts of Kratom. Deviant Behavior 41:10, pages 1258-1267.
Read now
Read now
Kirsten E. Smith, Amanda M. Bunting, Robert Walker, Martin T. Hall, Oliver Grundmann & Olivia Castillo. (2019) Non-Prescribed Buprenorphine Use Mediates the Relationship between Heroin Use and Kratom Use among a Sample of Polysubstance Users. Journal of Psychoactive Drugs 51:4, pages 311-322.
Read now
Read now
Darshan Singh$suffix/text()$suffix/text(), Suresh Narayanan$suffix/text()$suffix/text(), Christian P. Müller$suffix/text()$suffix/text(), Balasingam Vicknasingam$suffix/text()$suffix/text(), Murat Yücel$suffix/text()$suffix/text(), Eric Tatt Wei Ho$suffix/text()$suffix/text(), Zurina Hassan$suffix/text()$suffix/text() & Sharif Mahsufi Mansor$suffix/text()$suffix/text(). (2019) Long-Term Cognitive Effects of Kratom (Mitragyna speciosa Korth.) Use. Journal of Psychoactive Drugs 51:1, pages 19-27.
Read now
Read now
Darshan Singh, Suresh Narayanan, Christian P. Müller, Marc, T. Swogger, Azlan Abdul Rahim, Mohammad Farris Iman Leong Bin Abdullah & Balasingam K. Vicknasingam. (2018) Severity of Kratom (Mitragyna speciosa Korth.) Psychological Withdrawal Symptoms. Journal of Psychoactive Drugs 50:5, pages 445-450.
Read now
Read now
O. Hayden Griffin & Megan E. Webb. (2018) The Scheduling of Kratom and Selective Use of Data. Journal of Psychoactive Drugs 50:2, pages 114-120.
Read now
Read now
Articles from other publishers (16)
Jeffrey D. Feldman, Destiny Schriefer, Kirsten E. Smith, Stephanie T. Weiss, Gisela Butera, Kelly E. Dunn, Oliver Grundmann, Christopher R. McCurdy, Darshan Singh & David H. Epstein. (2023) Omissions, Ambiguities, and Underuse of Causal Assessment Tools: a Systematic Review of Case Reports on Patients Who Use Kratom. Current Addiction Reports 10:2, pages 293-303.
Crossref
Crossref
Stephanie T. Weiss & Jeffrey Brent. (2023) A Cautionary Tale of Herbal Supplements: What We Have Learned from Kratom. Current Addiction Reports 10:1, pages 1-8.
Crossref
Crossref
Murtadha Basheer, Rana Khudhair Jasim & Gam Lay Harn. (2022)
Controversial usages of kratom (
Mitragyna speciosa
): For good or for evil
. World Journal of Pharmacology 11:3, pages 16-26.
Crossref
Crossref
Walter Prozialeck, Alexandra Fowler & Joshua Edwards. (2022) Public Health Implications and Possible Sources of Lead (Pb) as a Contaminant of Poorly Regulated Kratom Products in the United States. Toxics 10:7, pages 398.
Crossref
Crossref
Kirsten E. Smith, Jeffrey M. Rogers, Kelly E. Dunn, Oliver Grundmann, Christopher R. McCurdy, Destiny Schriefer & David H. Epstein. (2022) Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships Among a Sample of US Adults With Regular Kratom Use Histories. Frontiers in Pharmacology 13.
Crossref
Crossref
Jeffrey M. Rogers, Kirsten E. Smith, Justin C. Strickland & David H. Epstein. (2021) Kratom Use in the US: Both a Regional Phenomenon and a White Middle-Class Phenomenon? Evidence From NSDUH 2019 and an Online Convenience Sample. Frontiers in Pharmacology 12.
Crossref
Crossref
Kirsten E. Smith, Jeffrey M. Rogers, Destiny Schriefer & Oliver Grundmann. (2021) Therapeutic benefit with caveats?: Analyzing social media data to understand the complexities of kratom use. Drug and Alcohol Dependence 226, pages 108879.
Crossref
Crossref
Mary Ellen Wright, Claire Ginsberg, Abigail M. Parkison, Melissa Dubose, Madison Sherbondy & Emily Shores. (2021) Outcomes of mothers and newborns to prenatal exposure to kratom: a systematic review. Journal of Perinatology 41:6, pages 1236-1243.
Crossref
Crossref
Walter C. Prozialeck, Joshua R. Edwards, Peter C. Lamar, Balbina J. Plotkin, Ira M. Sigar, Oliver Grundmann & Charles A. Veltri. (2020) Evaluation of the Mitragynine Content, Levels of Toxic Metals and the Presence of Microbes in Kratom Products Purchased in the Western Suburbs of Chicago. International Journal of Environmental Research and Public Health 17:15, pages 5512.
Crossref
Crossref
Rebecca S. Williams & Dmitriy Nikitin. (2020) The internet market for Kratom, an opioid alternative and variably legal recreational drug. International Journal of Drug Policy 78, pages 102715.
Crossref
Crossref
Nicole S. Jones & Jeffrey H. Comparin. (2020) Interpol review of controlled substances 2016–2019. Forensic Science International: Synergy 2, pages 608-669.
Crossref
Crossref
Deana Goldin, Deborah Salani & Mary Mckay. (2019) Kratom: Implications for Health Care Providers. Journal of Psychosocial Nursing and Mental Health Services 57:12, pages 15-20.
Crossref
Crossref
John M Corkery, Peter Streete, Hugh Claridge, Christine Goodair, Duccio Papanti, Laura Orsolini, Fabrizio Schifano, Kanav Sikka, Sophie Körber & Amy Hendricks. (2019) Characteristics of deaths associated with kratom use. Journal of Psychopharmacology 33:9, pages 1102-1123.
Crossref
Crossref
Darshan Singh, Christian P. Müller, Vikneswaran Murugaiyah, Shahrul Bariyah Sahul Hamid, Balasingam K. Vicknasingam, Bonnie Avery, Nelson Jeng Yeou Chear & Sharif Mahsufi Mansor. (2018) Evaluating the hematological and clinical-chemistry parameters of kratom (Mitragyna speciosa) users in Malaysia. Journal of Ethnopharmacology 214, pages 197-206.
Crossref
Crossref
O. Hayden GriffinIIIIII. 2018. Plant Medicines, Healing and Psychedelic Science. Plant Medicines, Healing and Psychedelic Science
71
85
.
Kirsten Elin Smith & Thomas Lawson. (2017) Prevalence and motivations for kratom use in a sample of substance users enrolled in a residential treatment program. Drug and Alcohol Dependence 180, pages 340-348.
Crossref
Crossref